SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001818382-22-000114
Filing Date
2022-09-01
Accepted
2022-09-01 16:14:22
Documents
13

Document Format Files

Seq Description Document Type Size
1 S-3 humas-3.htm S-3 525304
2 EX-FILING FEES shelfs-3exhibit107.htm EX-FILING FEES 32171
3 EX-1.2 humashelfatms-3xexhibit12.htm EX-1.2 269080
4 EX-4.6 huma20220901s-3exhibit46.htm EX-4.6 570462
5 EX-4.8 humashelfatms-3exhibit48.htm EX-4.8 622852
6 EX-5.1 humacyte-shelfsx3xexhibit51.htm EX-5.1 35823
7 EX-5.2 humacyte-shelfsx3xexhibit52.htm EX-5.2 10943
8 EX-23.3 huma20220901s-3exhibit233.htm EX-23.3 3024
9 humacytea.jpg GRAPHIC 15450
10 letterhead1.jpg GRAPHIC 50786
11 letterhead11.jpg GRAPHIC 50786
12 letterhead2.jpg GRAPHIC 11514
13 letterhead21.jpg GRAPHIC 11514
  Complete submission text file 0001818382-22-000114.txt   2242594
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267225 | Film No.: 221221100
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences